August 06, 2025

Bimekizumab Sustains Psoriasis Response for 3 Years

A 3-year analysis of a phase IIIb trial found that bimekizumab, a dual interleukin-17A and interleukin-17F inhibitor, maintained high rates of skin clearance and demonstrated a consistent safety profile in patients with moderate-to-severe plaque psoriasis, including those who switched from secukinumab, an interleukin-17A inhibitor.

Conexiant

August 05, 2025

Modified Mesh Repair Effective in Women’s Hernias

Randomized trial results showed that modified open mesh repair was as safe and effective as standard mesh repair for treating groin hernias in women, with similar recurrence and complication rates after 1 year.

Conexiant

August 05, 2025

Weight Regain Persists After Anti-Obesity Treatment

A new meta-analysis of 11 randomized controlled trials found that patients began regaining weight as early as 8 weeks after discontinuing anti-obesity medications, with weight gain continuing through 52 weeks.

Conexiant

July 11, 2025

Bariatric Surgeries Reverse Liver Fibrosis

Bariatric surgeries led to greater long-term reductions in liver fat and fibrosis than endoscopic options.

Conexiant

July 31, 2025

Fluorescent Agent Enables Clearer Nerve Visualization

A phase 1 clinical trial found that rizedisben, a fluorescent agent targeting myelin, enabled sustained nerve visualization during robotic prostate surgery at a 3.0 mg/kg dose with minimal side effects.

Conexiant

July 23, 2025

Ultrasound Combo Detects MASH and Fibrosis

Two ultrasound techniques show strong diagnostic performance for steatohepatitis and fibrosis, supporting a noninvasive alternative to biopsy.

Conexiant

July 11, 2025

Patients With Sludge Pancreatitis Have Fewer Complications

An international cohort study found that patients with sludge- or microlithiasis-induced acute pancreatitis had significantly fewer long-term complications than those with gallstone-related pancreatitis.

Conexiant

July 30, 2025

Ondansetron Cuts 7-Day Gastroenteritis Severity in Children, Study Finds

Home use of ondansetron following emergency care for pediatric gastroenteritis lowers the risk of moderate-to-severe illness within 7 days, without increasing serious adverse events.

Conexiant

July 29, 2025

Postpartum Pelvic Floor Disorders Often Overlooked, Review Finds

Emerging diagnostic tools such as dynamic ultrasound and anorectal manometry offer clinicians improved evaluation of postpartum pelvic floor disorders, yet standardized screening protocols remain limited.

Conexiant